{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T21:34:58Z","timestamp":1698788098520},"reference-count":25,"publisher":"Hindawi Limited","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3309,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2006.01069.x","type":"journal-article","created":{"date-parts":[[2006,8,10]],"date-time":"2006-08-10T12:38:59Z","timestamp":1155213539000},"page":"1060-1067","source":"Crossref","is-referenced-by-count":8,"title":["Pregabalin for peripheral neuropathic pain: results of a multicenter, non-comparative, open-label study in Indian patients"],"prefix":"10.1155","volume":"60","author":[{"name":"LYRICA STUDY GROUP","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2006,8,10]]},"reference":[{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB1|cit1","first-page":"441","article-title":"Current treatment options in neuropathic pain","volume":"3","author":"Hempenstall","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archneur.60.11.1524","article-title":"Advances in neuropathic pain: diagnosis, mechanisms and treatment recommendations","volume":"60","author":"Dworkin","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2165\/00003495-200060050-00005","article-title":"Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy","volume":"60","author":"Tremont-Lukats","year":"2000","journal-title":"Drugs"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11916-004-0054-4","article-title":"Neuromodulating drugs for the symptomatic treatment of neuropathic pain","volume":"8","author":"Backonja","year":"2004","journal-title":"Curr Pain Headache Rep"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.2165\/00003495-200464240-00006","article-title":"Pregabalin in the treatment of painful diabetic peripheral neuropathy","volume":"64","author":"Frampton","year":"2004","journal-title":"Drugs"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/01.WNL.0000055433.55136.55","article-title":"Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial","volume":"60","author":"Dworkin","year":"2003","journal-title":"Neurology"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2004.01.001","article-title":"Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial","volume":"109","author":"Sabatowski","year":"2004","journal-title":"Pain"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1212\/01.WNL.0000145767.36287.A1","article-title":"Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized clinical trial","volume":"63","author":"Lesser","year":"2004","journal-title":"Neurology"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","article-title":"Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial","volume":"110","author":"Rosenstock","year":"2004","journal-title":"Pain"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpain.2004.12.007","article-title":"Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial","volume":"6","author":"Richter","year":"2005","journal-title":"J Pain"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pain.2005.02.032","article-title":"Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens","volume":"115","author":"Freynhagen","year":"2005","journal-title":"Pain"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1185\/030079906X80404","article-title":"Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial","volume":"22","author":"Van Seventer","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","article-title":"The Short-Form McGill Pain Questionnaire","volume":"30","author":"Melzack","year":"1987","journal-title":"Pain"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB14|cit14","article-title":"Effectiveness and time to onset of pregabalin in patients with neuropathic pain","author":"Freynhagen","year":"2006","journal-title":"Schmerz"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB15|cit15","doi-asserted-by":"crossref","unstructured":"Cleeland CS Pain assessment in cancer Osoba D Effect of Cancer on Quality of Life CRC Press Inc. 293 305","DOI":"10.1201\/9781003068648-21"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpain.2003.12.005","article-title":"Validation of the Brief Pain Inventory for chronic nonmalignant pain","volume":"5","author":"Tan","year":"2004","journal-title":"J Pain"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQoL - a new facility for the measurement of health-related quality of life","volume":"16","author":"The EuroQoL Group","year":"1990","journal-title":"Health Policy"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/rheumatology\/36.5.551","article-title":"Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D)","volume":"36","author":"Hurst","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB20|cit20","volume-title":"ECDEU Assessment Manual for Psychopharmacology, Revised","author":"Guy","year":"1976"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB21|cit21","first-page":"S29","article-title":"Efficacy, safety, and tolerability of pregabalin treatment for neuropathic pain: findings from 11 clinical trials","volume":"6","author":"Sharma","year":"2005","journal-title":"J Pain"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockroft","year":"1976","journal-title":"Nephron"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jpain.2005.01.116","article-title":"Long-term treatment of neuropathic pain and fibromyalgia syndrome with pregabalin in treatment-refractory patients","volume":"6","author":"Dworkin","year":"2005","journal-title":"J Pain"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.20983","article-title":"Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial","volume":"52","author":"Crofford","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1742-1241.2006.01069.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jpain.2005.01.095","article-title":"Pregabalin safely and efficaciously treats chronic central neuropathic pain after spinal cord injury","volume":"6","author":"Siddal","year":"2005","journal-title":"J Pain"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2006.01069.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2006.01069.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T13:40:44Z","timestamp":1683553244000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2006.01069.x"}},"subtitle":["PREGABALIN FOR PERIPHERAL NEUROPATHIC PAIN IN INDIAN PATIENTS"],"short-title":[],"issued":{"date-parts":[[2006,8,10]]},"references-count":25,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2006.01069.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8,10]]}}}